IV Glutathione For Skin Lightening: Doctors Warn Against Trendy ‘Glow-Up’ Drips

Instagram Reels are increasingly filled with videos featuring ambient lighting, lo-fi music and sleek IV drips marketed as a shortcut to glowing, lighter skin. But two doctors have urged people to think twice before booking such treatments, warning about the potential health risks of intravenous skin-lightening procedures.

In a public health warning shared on Instagram on September 13, Dr Cyriac Abby Philips, a Kerala-based hepatologist popularly known as “The Liver Doc”, and Hyderabad-based paediatrician Dr Sivaranjani Santosh raised concerns over the growing use of IV glutathione at aesthetic and wellness clinics.

“Reminder. Cosmetology is not a real medical field. IV drip clinics are dangerous grounds,” the doctors said in their post.

Concerns Over ‘Cosmetologists’

The doctors highlighted what they described as a lack of adequate medical oversight at some aesthetic centres. They said patients can be misled by professional-sounding titles used in the cosmetic and wellness industry.

“This is mostly offered by ‘cosmetologists’ or by commercialised dermatology clinic chains,” they said.

According to the doctors, “cosmetology” is not a recognised medical degree or protected medical title under India’s National Medical Commission. They cautioned that the use of such titles does not necessarily indicate that an individual is a qualified medical practitioner.

The doctors described the aggressive promotion of cosmetic IV infusions as a “scam alert”.

Limited Evidence, Temporary Results

The doctors also questioned the scientific evidence behind IV glutathione for cosmetic skin lightening.

“The clinical evidence supporting IV glutathione is exceptionally poor,” they said, adding that marketing claims are largely based on anecdotal reports and a single criticised study with a small sample size, poor design and concerns over the reliability of its evaluators.

They further warned that any skin-lightening effect is temporary.

“Because the body continuously produces melanin, any potential lightening effect is temporary. Once the extreme systemic doses are stopped, the skin’s natural pigmentation returns,” they said.

According to the doctors, this could leave users repeatedly paying for a treatment that offers no permanent change.

Safety Concerns Around IV Formulations

The warning also focused on the risks associated with intravenous formulations administered in wellness clinics.

Since IV glutathione is not approved specifically for cosmetic skin lightening, the doctors said some clinics may rely on customised or compounded preparations.

“IV glutathione in ‘wellness’ clinics is not as safe as it seems,” they cautioned.

They explained that compounded drugs are medications prepared by combining, mixing or altering ingredients rather than being supplied as standard commercially manufactured formulations. The doctors warned that this can introduce additional safety concerns when products are not manufactured and handled to appropriate pharmaceutical standards.

FDA Warning Cited By Doctors

The doctors also pointed to an August 2026 US Food and Drug Administration safety warning involving glutathione IV treatments.

According to their post, dozens of patients developed potentially serious infection or sepsis-like symptoms, including fever, chills and low blood pressure, after receiving glutathione infusions. Some required hospitalisation.

The doctors said clinics involved in the cases had been compounding IV treatments using dietary supplement-grade powder that contained dangerously high levels of bacterial endotoxins.

“The harms are real. People nearly died,” they said.

Severe Adverse Reactions

The Instagram advisory also carried a trigger warning for graphic medical images and highlighted potentially severe reactions associated with high-dose glutathione administration.

“Sometimes the adverse events are terrifying,” the doctors said.

They cited possible complications including anaphylaxis, acute liver and kidney dysfunction, and severe skin reactions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), both of which can be life-threatening.

Doctors’ Warning: ‘Not Healthcare’

The doctors concluded by arguing that commercial interests can overshadow patient safety when cosmetic IV treatments are aggressively marketed.

“It is all business. Not healthcare,” they said.

They described IV glutathione in dermatology and cosmetology clinics as a lucrative marketing trend operating outside evidence-based medicine and urged people not to undergo the treatment simply for cosmetic skin lightening.

“Like I said, absolutely, do not do this,” they concluded.